GlassScriptPhysician profile
Louis Borgatta
NPI 1942290390
$6,695.32
in general payments reported to CMS, 2019-2025
23 companies · $815 in 2025
The $815 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,696 · 2020: $288 · 2021: $395 · 2022: $491 · 2023: $155 · 2024: $2,856 · 2025: $815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,122 · Food and Beverage: $1,703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,122.26 |
| Food and Beverage | $1,703.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,013.81 | 2021-2025 | Selectsecure, Cobalt Dr Mri Surescan |
| Biotronik INC. | $566.34 | 2023-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Janssen Pharmaceuticals, INC | $371.64 | 2019-2024 | Xarelto |
| Edwards Lifesciences Corporation | $367.30 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $289.33 | 2019-2021 | |
| Amarin Pharma, INC. | $254.17 | 2019-2022 | |
| Medtronic Vascular, INC. | $206.33 | 2019-2020 | |
| Amgen INC. | $200.19 | 2019-2020 | |
| Abbott Laboratories | $176.12 | 2019-2025 | Amplatzer Amulet |
| E.R. Squibb & Sons, L.L.C. | $163.09 | 2022-2024 | Camzyos, Eliquis |
| Boston Scientific Corporation | $160.15 | 2019-2025 | Sq-Rx Pulse Generator |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $157.50 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $144.60 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $124.00 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $113.43 | 2019 | |
| Novartis Pharmaceuticals Corporation | $94.85 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $73.75 | 2019 | |
| Terumo Medical Corporation | $22.13 | 2025 | Angio-Seal |
| Abiomed | $21.48 | 2020 | |
| Chiesi USA, INC. | $20.33 | 2020 | |
| Merck Sharp & Dohme LLC | $16.34 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Borgatta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.